Barrett MJ

References (3)

Title : Anticholinergic Medication Burden in Parkinson's Disease Outpatients - Nawaz_2021_J.Parkinsons.Dis__
Author(s) : Nawaz H , Sargent L , Quilon H , Cloud LJ , Testa CM , Snider JD , Lageman SK , Baron MS , Berman BD , Zimmerman K , Price ET , Mukhopadhyay ND , Barrett MJ
Ref : J Parkinsons Dis , : , 2021
Abstract : Nawaz_2021_J.Parkinsons.Dis__
ESTHER : Nawaz_2021_J.Parkinsons.Dis__
PubMedSearch : Nawaz_2021_J.Parkinsons.Dis__
PubMedID: 34806617

Title : Therapeutic approaches to cholinergic deficiency in Lewy body diseases - Barrett_2020_Expert.Rev.Neurother_20_41
Author(s) : Barrett MJ , Cloud LJ , Shah H , Holloway KL
Ref : Expert Rev Neurother , 20 :41 , 2020
Abstract : Barrett_2020_Expert.Rev.Neurother_20_41
ESTHER : Barrett_2020_Expert.Rev.Neurother_20_41
PubMedSearch : Barrett_2020_Expert.Rev.Neurother_20_41
PubMedID: 31577469

Title : Cognitive and Antipsychotic Medication Use in Monoallelic GBA-Related Parkinson Disease - Barrett_2014_JIMD.Rep_16_31
Author(s) : Barrett MJ , Shanker VL , Severt WL , Raymond D , Gross SJ , Schreiber-Agus N , Kornreich R , Ozelius LJ , Bressman SB , Saunders-Pullman R
Ref : JIMD Rep , 16 :31 , 2014
Abstract : Barrett_2014_JIMD.Rep_16_31
ESTHER : Barrett_2014_JIMD.Rep_16_31
PubMedSearch : Barrett_2014_JIMD.Rep_16_31
PubMedID: 24850235